Global Lacosamide
Market Report
2024
Lacosamide Market size is USD 5815.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 5.00% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Lacosamide Market Report 2024.
According to Cognitive Market Research, the global Lacosamide market size is USD 5815.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 5.00% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global Lacosamide Market Sales Revenue 2024 | $ 5815.2 Million |
Global Lacosamide Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5% |
North America Lacosamide Market Sales Revenue 2024 | $ 2326.08 Million |
North America Lacosamide Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.2% |
Europe Lacosamide Market Sales Revenue 2024 | $ 1744.56 Million |
Europe Lacosamide Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.5% |
Asia Pacific Lacosamide Market Sales Revenue 2024 | $ 1337.5 Million |
Asia Pacific Lacosamide Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7% |
South America Lacosamide Market Sales Revenue 2024 | $ 290.76 Million |
South America Lacosamide Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.4% |
Middle East and Africa Lacosamide Market Sales Revenue 2024 | $ 116.3 Million |
Middle East and Africa Lacosamide Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.7% |
Market Split by Type |
|
Market Split by Application |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Lacosamide industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Lacosamide Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The pharmaceutical industry that produces, distributes, and uses lacosamide is the focus of the lacosamide market. Lacosamide is a medicine that is mostly recommended to treat diabetic neuropathic pain and partial-onset seizures in epilepsy. Lacosamide calms down hyperactive nerve cells in the spinal cord and brain. Its ability to effectively control seizures and manage neuropathic pain has made it a prominent therapy choice in the market for antiepileptic drugs. The market for lacosamide is anticipated to grow steadily as awareness of neurological diseases and neuropathic pain conditions rises and as long as research and development efforts are continued. Its commercial landscape is still being shaped, though, by issues with side effects, safety concerns, and competition
Effective therapies are in high demand due to the increasing frequency of epilepsy, a neurological illness that affects millions of people worldwide. One of the main factors influencing the management of partial-onset seizures is the effectiveness of lacosamide as an adjuvant treatment. Furthermore, lacosamide's usefulness includes the management of diabetic neuropathic pain, an increasingly pressing issue given the rising prevalence of diabetes. The dual role of lacosamide in treating both epilepsy and neuropathic pain highlights its significance in giving relief and enhancing the quality of life for people suffering from these crippling disorders, as neuropathic pain poses significant obstacles to patient well-being.
The growing body of clinical evidence and the manifestation of efficacious use cases about lacosamide have significantly bolstered the knowledge and assurance of medical practitioners in recommending this drug. Doctors are adding more and more lacosamide to their treatment plans as they learn more about its effectiveness and safety profile in treating illnesses, including diabetic neuropathic pain and partial-onset seizures. Expanding patient access to lacosamide and market growth are the outcomes of healthcare providers' increasing acceptance and familiarity with the drug. In the end, increased understanding and acceptance by medical professionals are critical to enhancing patient outcomes and meeting unmet medical needs in the treatment of neuropathic pain and neurological illnesses.
Although partial-onset seizures and diabetic neuropathic pain have been successfully treated with lacosamide, it is important to be aware of the possible side effects and safety issues that come with using this medication. Like many drugs, lacosamide can cause mild to severe adverse reactions in certain patients. Headache, nausea, dizziness, and sleepiness are typical adverse effects. But there have also been reports of more severe side effects, like heart arrhythmias and psychological issues. When prescribing lacosamide, doctors must carefully balance the advantages of the drug against the possibility of side effects. This will help ensure patients receive the best care possible while reducing the likelihood of negative results. Maintaining patient adherence and maximizing therapy outcomes depend heavily on managing lacosamide side effects and safety concerns.
The COVID-19 pandemic has impacted the market for lacosamide in many ways. Antiepileptic drug demand stayed mostly steady. However, prescriptions temporarily decreased due to patient resistance to seeking care during lockdowns and disruptions in healthcare access. Production difficulties and supply chain interruptions also impacted market dynamics. However, the market for lacosamide recovered when patient care resumed and healthcare systems adjusted to the epidemic. Moreover, a renewed emphasis on managing epilepsy as a result of the pandemic's enhanced awareness of neurological conditions and mental health problems may have increased demand for lacosamide and other antiepileptic medications in the post-pandemic environment.
We have various report editions of Lacosamide Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D to introduce cutting-edge reagents, ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.
Top Companies Market Share in Lacosamide Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. The market for lacosamide is expanding in North America due to a number of factors, including the availability of cutting-edge medical infrastructure, rising awareness among healthcare professionals, and the prevalence of neurological illnesses. The region's lacosamide market is also growing as a result of continuous research and development initiatives meant to improve treatment alternatives for ailments like neuropathic pain and epilepsy.
The Europe region is witnessing an increase, in the sales of reagents. The market for lacosamide is growing in Europe as a result of factors such the rise in neurological illnesses, the expansion of the healthcare system, and the growing acceptance of cutting-edge treatment alternatives. Market expansion is also aided by strict regulatory frameworks and a focus on patient safety. Europe is expected to experience sustained expansion in the lacosamide market, with an emphasis on meeting unmet medical needs.
The current report Scope analyzes Lacosamide Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
According to Cognitive Market Research, the global Lacosamide market size was estimated at USD 5815.2Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 2326.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031. The market for lacosamide is expanding rapidly in North America due to the rising incidence of neurological conditions such as epilepsy and diabetic neuropathic pain. Because of the well-established healthcare system and growing knowledge among medical experts, lacosamide is frequently recommended as a successful treatment choice. The increased prevalence of these illnesses among adults makes the adult segment particularly important for market expansion. North America's focus on patient-centered care and continuous breakthroughs in treatment alternatives will propel the lacosamide market's growth, improving outcomes for those with neurological illnesses.
Country Analysis
According to Cognitive Market Research, with a market value of USD 5815.2 million in 2024 and projected to expand at a compound annual growth rate (CAGR) of 3.5% from 2024 to 2031. Europe accounted for a share of over 30% of the global market size of USD 1744.56 million. The market for lacosamide is steadily expanding in Europe, driven by a rise in the prevalence of neurological conditions like epilepsy and neuropathic pain. Accosamide is a commonly used therapy choice because of the strong healthcare infrastructure and strict regulatory requirements in place. The pediatric market is especially significant since children with epilepsy are increasingly using lacosamide thanks to developments in pediatric medicine. Europe continues to be a key player in propelling the lacosamide market's expansion, guaranteeing improved management of neurological diseases throughout the region, with an emphasis on meeting unmet medical needs and improving patient outcomes.
According to Cognitive Market Research, the global Lacosamide market size was estimated at USD 5815.2Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 1337.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031. The market for lacosamide is expanding significantly in the Asia Pacific area due to the increased occurrence of neurological conditions such neuropathic pain and epilepsy. The growing awareness among healthcare professionals and the advancement of healthcare infrastructure make lacosamide an essential therapy option. Because these illnesses are more common in adults, the adult group is driving market demand. In order to meet the needs of people with neurological illnesses throughout the region, Asia Pacific is well-positioned to continue driving the expansion of the lacosamide market thanks to continuous advancements in medical technology and improved access to healthcare services.
According to Cognitive Market Research, the global Lacosamide market size was estimated at USD 5815.2Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 290.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031. The market for lacosamide is steadily expanding in Latin America due to the rising incidence of neurological conditions like epilepsy and neuropathic pain. Despite obstacles in the healthcare system, lacosamide is becoming more and more popular as a therapeutic choice. Because these illnesses are more common in adults, the adult segment accounts for a large share of market demand. Latin America is a major contributor to the lacosamide market expansion, which benefits patient treatment for those with neurological illnesses in the region. This growth in the market is attributed to a growing emphasis on solving unmet medical requirements and expanding healthcare access.
According to Cognitive Market Research, the global Lacosamide market size was estimated at USD 5815.2Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 116.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031. The market for lacosamide is gradually expanding in the Middle East and Africa due to the rising incidence of neurological conditions like epilepsy and neuropathic pain. Despite obstacles to access and infrastructure in healthcare, lacosamide is showing promise as a useful therapeutic choice. Because these illnesses are more common in adults, the adult group is driving market demand. The Middle East and Africa region is in a good position to positively impact patient outcomes by contributing to the growth of the lacosamide market, given its continuous efforts to address unmet medical requirements and improve healthcare services.
Global Lacosamide Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Lacosamide Industry growth. Lacosamide market has been segmented with the help of its Type, Application , and others. Lacosamide market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
According to Cognitive Market Research, Oral solutions held the major market share over the forecast period. The market for lacosamide is expanding as a result of the launch of oral solutions. For people who have trouble swallowing pills or capsules, oral solutions provide simple options for dosing. By reaching a wider patient base, this invention increases patient adherence to treatment plans and broadens the lacosamide market. The general accessibility and extension of lacosamide therapy is facilitated by the availability of oral solutions.
Intravenous is the fastest-growing category over the forecast period. The intravenous lacosamide formulations' acceptance and accessibility are driving the lacosamide market's expansion. When a patient is unable to take oral medication or in an emergency, intravenous administration may be chosen due to its quick beginning of action. The augmentation of administration possibilities for lacosamide augments its adaptability and effectiveness, hence bolstering its market growth and increasing its use.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Lacosamide Industry. Request a Free Sample PDF!
According to Cognitive Market Research, Adults hold a prominent market share. One of the major factors propelling the lacosamide market is the increasing incidence of neurological illnesses in adults. With the growing adult population comes a greater need for efficient therapies for ailments including diabetic neuropathic pain and epilepsy. Due to its effectiveness in treating these conditions, lacosamide is viewed as a preferable course of treatment, which has led to the market's overall increase in the adult population.
Pediatric patients is the fastest-growing category over the forecast period. Because of the rising prevalence of neuropathic pain and epilepsy in children, the pediatric market is starting to show signs of strength. Lacosamide is a useful therapy choice for pediatric populations due to its efficacy and safety profile. The use of lacosamide is anticipated to increase due to the rising focus on pediatric healthcare and developments in pediatric medicine.
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Lacosamide market report 2024 Edition by contacting our team.
Senior Research Analyst at Cognitive Market Research
• Worked on several market, industry & business research projects, on various models such as Syndicated, Custom, Subscriptions and Consults
• Proficient in secondary research and familiar with all paid research databases
• Proficient in primary research and handling client queries through mails and calls
• Expertise in statistical techniques used in data forecasting, possess strong grip on all aspects of market engineering & data analysis
• Expertise in checking feasibility of projects based on Request for Proposal (RFPs) of clients
• Acquainted with entire process of report writing- Title Analysis, TOC Building, Search Engine Optimization, TOC Freezing, Writing Reports, Market Engineering, Scheduling Primaries, Directory of Key Industry Participants (DKIP), Drafting “Press Articles/Summary/Report Description/Analyst Briefing” used for making marketing collaterals
• Gained team-work skills in coordinating with the sales teams for business development and meeting needs of a variety of clients hand-in-hand with promoting sales.
I am a dynamic and results-driven research analyst with a passion for transforming raw data into actionable insights. Armed with a solid foundation in market research and data analysis, I thrive on the challenge of uncovering patterns, trends, and opportunities that drive strategic decision-making. My analytical mindset, coupled with effective communication skills, allows me to bridge the gap between data analysis and practical business applications.
I served as a key player in market research and competitive analysis. I have a proven track record of synthesizing disparate data sources, employing statistical models, and delivering comprehensive insights. Collaborating across departments, I played a pivotal role in shaping evidence-based strategies that fueled the success of key business initiatives. I am committed to ongoing professional development, participating in industry conferences, workshops, and pursuing additional certifications to stay at the forefront of research methodologies.
Disclaimer:
Type | Tablets, Oral solutions, Intravenous |
Application | Adults, Pediatric patients |
List of Competitors | Becton Dickinson and Company, Agilent Technologies Inc., Merck & Co. Inc., Waters Corporation, Abbott Laboratories, Johnson & Johnson, Promega Corporation, Sino Biological Inc., Siemens Healthineers, Roche Holding AG, Bio-Rad Laboratories, Thermo Fisher Scientific Inc UCB, Teva, Amneal Pharmaceuticals, MSN Laboratories, Alembic Pharma, Glenmark, Aurobindo Pharma, Accord Healthcare, Mylan, Sun Pharma, Apotex. |
This chapter will help you gain GLOBAL Market Analysis of Lacosamide. Further deep in this chapter, you will be able to review Global Lacosamide Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
Chapter 2 North America Market Analysis
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
Qualitative Analysis for the North America Market: North America Lacosamide Market Trends North America Lacosamide Technological Road Map North America Lacosamide Market Drivers North America Lacosamide Market Restraints North America Lacosamide Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
Chapter 3 Europe Market Analysis
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
Chapter 4 Asia-Pacific Market Analysis
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
Chapter 5 South America Market Analysis
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
Chapter 6 Middle East and Africa Market Analysis
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Lacosamide market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Tablets have a significant impact on Lacosamide market? |
What are the key factors affecting the Tablets and Oral solutions of Lacosamide Market? |
What is the CAGR/Growth Rate of Adults during the forecast period? |
By type, which segment accounted for largest share of the global Lacosamide Market? |
Which region is expected to dominate the global Lacosamide Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Lacosamide Market
Request Sample